Wang Y - Search Results

1

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm.

Wang Y, Patel A, Douglas RS. Wang Y, et al. Ther Clin Risk Manag. 2019 Nov 11;15:1305-1318. doi: 10.2147/TCRM.S193018. eCollection 2019. Ther Clin Risk Manag. 2019. PMID: 31814726 Free PMC article. Review.

2

Management of Postblepharoplasty Lower Eyelid Retraction.

Patel A, Wang Y, Massry GG. Patel A, et al. Among authors: wang y. Facial Plast Surg Clin North Am. 2019 Nov;27(4):425-434. doi: 10.1016/j.fsc.2019.07.014. Epub 2019 Aug 30. Facial Plast Surg Clin North Am. 2019. PMID: 31587762 Review.

3

Dermal Onlay Grafts: A Rescue Procedure for Secondary Inferior Periorbital Hollows.

Wang Y, Douglas RS, Patel A, Holds J, Massry GG. Wang Y, et al. Aesthet Surg J. 2021 Mar 12;41(4):418-425. doi: 10.1093/asj/sjaa211. Aesthet Surg J. 2021. PMID: 32697293

4

Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States.

Wang Y, Sharma A, Padnick-Silver L, Francis-Sedlak M, Holt RJ, Foley C, Massry G, Douglas RS. Wang Y, et al. J Endocr Soc. 2020 Sep 25;4(12):bvaa140. doi: 10.1210/jendso/bvaa140. eCollection 2020 Dec 1. J Endocr Soc. 2020. PMID: 33195953 Free PMC article.

5

Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.

Wang Y, Sharma A, Padnick-Silver L, Francis-Sedlak M, Holt RJ, Foley C, Massry G, Douglas RS. Wang Y, et al. Ophthalmol Ther. 2021 Mar;10(1):75-87. doi: 10.1007/s40123-020-00318-x. Epub 2020 Nov 16. Ophthalmol Ther. 2021. PMID: 33196932 Free PMC article.

6

Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression.

Ugradar S, Shi L, Wang Y, Mester T, Yang H, Douglas RS. Ugradar S, et al. Among authors: wang y. Eye (Lond). 2021 Sep;35(9):2607-2612. doi: 10.1038/s41433-020-01297-w. Epub 2020 Nov 21. Eye (Lond). 2021. PMID: 33221815 Free PMC article.

7

Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

Douglas RS, Wang Y, Dailey RA, Harris GJ, Wester ST, Schiffman JS, Tang RA, Fowler B, Fleming J, Smith TJ. Douglas RS, et al. Among authors: wang y. J Neuroophthalmol. 2021 Dec 1;41(4):461-468. doi: 10.1097/WNO.0000000000001134. J Neuroophthalmol. 2021. PMID: 33417417 Free PMC article.

8

Improvement of asymmetric thyroid eye disease with teprotumumab.

Ugradar S, Wang Y, Mester T, Kahaly GJ, Douglas R. Ugradar S, et al. Among authors: wang y. Br J Ophthalmol. 2022 Jun;106(6):755-759. doi: 10.1136/bjophthalmol-2020-318314. Epub 2021 Feb 12. Br J Ophthalmol. 2022. PMID: 33579690 Free PMC article. Clinical Trial.

9

The Spectrum of Aesthetic Canthal Suspension.

Wang Y, Holds JB, Douglas RS, Massry GG. Wang Y, et al. Facial Plast Surg Clin North Am. 2021 May;29(2):275-289. doi: 10.1016/j.fsc.2021.01.005. Epub 2021 Apr 24. Facial Plast Surg Clin North Am. 2021. PMID: 33906760 Review.

10

The Prominent Eye-What to Watch Out For.

Landsberger H, Wang Y, Douglas RS. Landsberger H, et al. Among authors: wang y. Facial Plast Surg Clin North Am. 2021 May;29(2):311-321. doi: 10.1016/j.fsc.2021.02.004. Epub 2021 Apr 24. Facial Plast Surg Clin North Am. 2021. PMID: 33906763 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295,993 results

Search Page

Filters